SGLT2i, Pioglitazone, and Ketone Production in T2D

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To examine whether the empagliflozin-induced stimulation of EGP, lipolysis, and ketone production in T2D individuals can be blocked by pioglitazone (which has direct hepatic and adipose tissue effects).
Epistemonikos ID: c8d40ace85a6e7458f99747f323aaffbb14b6c2a
First added on: Jul 09, 2025